Runge, M.; Karimian, Z.; Kheirandish, M.; Borghi, G.; Wodniak, N.; Fahmy, K.; Mantel, C.; Cherian, T.; Nabil Ahmed Said, Z.; Najafi, F.;
et al. COVID-19 Vaccine Effectiveness Studies against Symptomatic and Severe Outcomes during the Omicron Period in Four Countries in the Eastern Mediterranean Region. Vaccines 2024, 12, 906.
https://doi.org/10.3390/vaccines12080906
AMA Style
Runge M, Karimian Z, Kheirandish M, Borghi G, Wodniak N, Fahmy K, Mantel C, Cherian T, Nabil Ahmed Said Z, Najafi F,
et al. COVID-19 Vaccine Effectiveness Studies against Symptomatic and Severe Outcomes during the Omicron Period in Four Countries in the Eastern Mediterranean Region. Vaccines. 2024; 12(8):906.
https://doi.org/10.3390/vaccines12080906
Chicago/Turabian Style
Runge, Manuela, Zahra Karimian, Mehrnaz Kheirandish, Giulio Borghi, Natalie Wodniak, Kamal Fahmy, Carsten Mantel, Thomas Cherian, Zeinab Nabil Ahmed Said, Farid Najafi,
and et al. 2024. "COVID-19 Vaccine Effectiveness Studies against Symptomatic and Severe Outcomes during the Omicron Period in Four Countries in the Eastern Mediterranean Region" Vaccines 12, no. 8: 906.
https://doi.org/10.3390/vaccines12080906
APA Style
Runge, M., Karimian, Z., Kheirandish, M., Borghi, G., Wodniak, N., Fahmy, K., Mantel, C., Cherian, T., Nabil Ahmed Said, Z., Najafi, F., Thneibat, F., Ul-Haq, Z., Fazid, S., Ibrahim Salama, I., Khosravi Shadmani, F., Alrawashdeh, A., Sirous, S., Bellizzi, S., Ahmed, A.,
... on behalf of the Consortium of Authors.
(2024). COVID-19 Vaccine Effectiveness Studies against Symptomatic and Severe Outcomes during the Omicron Period in Four Countries in the Eastern Mediterranean Region. Vaccines, 12(8), 906.
https://doi.org/10.3390/vaccines12080906
